IGF1 and hepatocellular carcinoma: T-ICs subsequently release IGF-1 to prevent miR-122 production in neighbouring normal hepatocytes and thereby curtail its intercellular transfer within exosomes, leading to low levels of the anti-proliferative miRNA in HCC cells.